For generations, the safety of chemicals has been measured in part through the suffering of animals — a practice long recognized as imperfect, both ethically and scientifically. Now, the European Union is formalizing a path away from that tradition, publishing a roadmap to phase out animal testing in chemical safety assessment and centering its hopes on a structured algorithm called ASPA, which weaves together computer models, human cell data, and exposure science into a single, traceable judgment. The deeper question this moment raises is not merely technical but civilizational: whether human
EU Advances Animal-Free Chemical Safety Testing With ASPA Workflow
Every decision gets documented and justified for regulators to see.
Mark
So this ASPA thing—is it basically saying we can just stop using animals to test chemicals?
Mimi
Not quite yet. It's a framework that makes animal-free testing possible, but regulatory authorities still need to accept it. The workflow itself is ready; the challenge is getting regulators to trust it enough to use it in official decisions.
Luke
How much of this is actually validated? The article mentions case studies, but one OECD study doesn't mean the whole system works across all chemicals.
Mimi
Fair point. They've done some validation work, but Escher herself says the real challenge is "continued validating these models so that regulatory authorities accept them." It's not done yet.
Mark
What makes ASPA different from just running a bunch of computer models and cell tests separately?
Mimi
The 55 assessment elements and the software that guides you through them. It's the structure and transparency. Every decision gets documented and justified. A regulator can see exactly why you reached your conclusion.
Luke
But who decides if the justification is good enough? That's still a human judgment call, right?
Mimi
Yes. ASPA makes the process reproducible and traceable, but it doesn't remove the need for expert judgment. It just makes that judgment visible.
Mark
The article mentions PBK models for inhalable substances. Why is that important?
Mimi
Because inhalation is a major exposure route for chemicals, and existing models were too simplified. Fraunhofer ITEM built models that better represent how the lungs actually work, which means better predictions of what happens in a real human body.
Luke
And they've tested this on actual inhalable substances?
Mimi
They've done case studies and validation work, but the article doesn't say how many real-world chemicals have been fully assessed this way yet. That's still being built out.
Mark
So when does this actually replace animal testing?
Mimi
That depends on regulatory acceptance. The EU roadmap is in place, but it's a gradual phase-out, not an overnight switch. Commercial labs need guidance on how to use these methods, and regulators need to formally accept them in their decision-making processes.
O Pulso
- Decades of ethical pressure and scientific limitation have converged into a formal EU commitment to end animal testing in chemical safety — and the clock is now ticking.
- ASPA, a modular algorithm built from 55 assessment steps, promises regulators something animal studies often cannot: full transparency into every decision, every data source, every conclusion.
- The gap between scientific readiness and regulatory acceptance is the live fault line — many of these methods are mature, yet official guidance has not caught up.
- Fraunhofer ITEM's physiologically based kinetic models are pushing the frontier further, translating lab-dish measurements into realistic human-body exposures for gases and aerosols.
- A successful OECD case study using machine learning and omics data has demonstrated that computational toxicology can identify dangerous substances early — but demonstration and adoption are not the same thing.
For generations, the safety of chemicals has been measured in part through the suffering of animals — a practice long recognized as imperfect, both ethically and scientifically. Now, the European Union is formalizing a path away from that tradition, publishing a roadmap to phase out animal testing in chemical safety assessment and centering its hopes on a structured algorithm called ASPA, which weaves together computer models, human cell data, and exposure science into a single, traceable judgment. The deeper question this moment raises is not merely technical but civilizational: whether human ingenuity has matured enough to protect itself without borrowing harm from other creatures.
The European Union is charting a course toward chemical safety assessment without animal testing. The European Commission has published a formal roadmap for this transition, and at its center sits ASPA — the Alternative Safety Profiling Algorithm — a structured, modular workflow built to replace animal studies with computer models and human cell cultures.
ASPA emerged from a collaboration of three EU-funded research projects and was developed with significant contributions from Fraunhofer ITEM, a German research institute. The workflow integrates biological activity data from human-relevant cell cultures and computational simulations with information about how the body absorbs and processes chemicals. Its three pillars — toxicokinetics, hazard identification, and exposure assessment — are operationalized through approximately 55 distinct assessment modules, each documented and reproducible through a companion software tool called ASPA-assist.
The transparency ASPA offers is one of its most important features. Regulators reviewing a submission can trace every step, every data source, and every conclusion — a level of auditability that traditional animal testing cannot always match. Fraunhofer ITEM has contributed particularly in the area of physiologically based kinetic models, mathematical simulations that translate laboratory measurements into realistic estimates of chemical exposure inside a human body, including for inhaled gases and aerosols.
A recent OECD case study put these methods to the test, combining high-throughput cell assays, biokinetic modeling, and machine learning to identify potentially toxic substances early. The results were promising, demonstrating that computational approaches can meaningfully support regulatory decisions.
Yet the critical challenge remains unchanged: scientific validation and regulatory acceptance do not move at the same speed. Many of these methods are already mature; the harder work is embedding them into official guidance so that commercial laboratories can offer them routinely. The European Commission is actively incorporating findings from these research projects, but this is a managed transition — not an immediate end to all animal testing. Whether regulatory ambition and scientific progress stay in step will determine how quickly this shift becomes reality.
The European Union is moving toward a future where chemical safety can be assessed without testing on animals. The European Commission has published a roadmap for gradually phasing out animal testing in chemical safety evaluation, and at the center of this shift sits a tool called ASPA—the Alternative Safety Profiling Algorithm—a structured workflow designed to replace animal studies with computer models and human cell cultures.
For decades, the EU has pursued what researchers call the 3Rs principle: replacement, reduction, and refinement of animal testing. ASPA represents the replacement part of that equation. Developed by a collaboration of three EU-funded research projects—ONTOX, PrecisionTox, and RISK-HUNT3R—the workflow offers a transparent, reproducible method for assessing chemical risks using only animal-free approaches. Researchers at Fraunhofer ITEM, a German research institute, played a central role in building ASPA and continue to refine it.
The workflow functions as a decision algorithm that integrates multiple sources of information into a single assessment. It pulls together biological activity data from new approach methodologies (NAMs)—which include human-relevant cell cultures and computer simulations—along with information about how the human body absorbs, distributes, metabolizes, and excretes chemicals. The system rests on three main pillars: toxicokinetics, hazard identification, and exposure assessment. To make this work, ASPA comprises approximately 55 distinct assessment elements, each one a modular step in the risk analysis process. A supporting software tool called ASPA-assist guides users through these 55 modules, ensuring that every decision is documented, justified, and reproducible.
Sylvia Escher, a research scientist at Fraunhofer ITEM, explains the appeal: "The ASPA workflow is a transparent, reproducible and modular approach to animal-free Next Generation Risk Assessment of chemicals." The transparency matters enormously for regulatory authorities. When a chemical company or researcher submits a safety assessment using ASPA, regulators can see exactly which steps were taken, which data were used, and how the final conclusion was reached. This traceability is something traditional animal testing cannot always provide.
One of Fraunhofer ITEM's key contributions has been the development of physiologically based kinetic (PBK) models—mathematical simulations that represent how the human body processes chemicals. These models translate biological processes into equations based on anatomical and physiological data. The institute has specialized in PBK models for inhalable substances, including gases and aerosols, an area where existing models had been limited. By combining these kinetic models with in vitro test results—measurements taken in cell cultures—researchers can convert doses measured in a laboratory dish into realistic doses that would occur in an actual human body exposed to the same chemical.
To test whether ASPA and its component methods actually work in practice, researchers conducted an OECD case study that combined high-throughput cell assays, biokinetic modeling, and machine learning. The goal was to identify substances with potential systemic toxicity early in the assessment process. The team used extensive molecular and cellular data—what researchers call omics data—to characterize how different chemicals affected cells at the molecular level. This data-driven approach successfully identified which features were most predictive of toxicity, demonstrating that modern computational methods can support regulatory decision-making.
But moving from research success to regulatory acceptance remains the critical hurdle. Many new approach methodologies have existed for years and are scientifically mature. The real challenge, as Escher notes, is continued validation and integration into official regulatory guidance. The European Commission is formally incorporating methods developed through projects like RISK-HUNT3R, but this is a coordinated transition, not an immediate ban on all animal testing. Regulatory authorities must be convinced that these new methods are reliable enough to replace animal studies in official safety assessments. The hope is that learnings from current research will be translated into new industry guidance, allowing commercial laboratories to offer these services widely. For now, the field watches to see whether the scientific validation keeps pace with regulatory ambition.
Citações Notáveis
The ASPA workflow is a transparent, reproducible and modular approach to animal-free Next Generation Risk Assessment of chemicals.— Sylvia Escher, research scientist at Fraunhofer ITEM
The real challenge is to continue validating these models so that regulatory authorities accept them and integrate them into regulatory processes.— Sylvia Escher, Fraunhofer ITEM
Quer a matéria completa?
Leia o original em chemeurope.com ↗
Politics & Governance